by IgNS | Mar 14, 2020 | Latest News
COVID-19 Update IgNS thanks all healthcare professionals and service providers, first responders, government agencies, and the healthcare industry who are working tirelessly in the face of the COVID-19 pandemic. Roche receives emergency approval for COVID-19... 
by IgNS | Feb 27, 2020 | Latest News
Novel Coronavirus (COVID-19 or SARS-CoV-2) and Plasma Safety IgNS Statement Regarding the Novel Coronavirus (COVID-19 or SARS-CoV-2) The recent outbreak of the 2019 Novel Coronavirus (COVID-19 or SARS-CoV-2) has raised awareness around the safety of plasma... by IgNS | Sep 24, 2019 | Latest News
On Sept. 23, the Healthcare Quality and Safety team at USP issued a letter announcing that it would delay the planned Dec. 1 implementation of three of its chapters: the revised <795> Pharmaceutical Compounding—Nonsterile Preparations and <797>... by IgNS | Aug 28, 2019 | Uncategorized
<script type="text/javascript"... by IgNS | Aug 6, 2019 | Podcasts
Immunoglobulin (Ig) is an indispensable therapy used to treat many autoimmune disorders, immunosuppressive disorders, idiopathic diseases, infections, and a myriad of other conditions. Ig is a plasma-derived therapy that originates with a human donor. Production of Ig... 